Largus Fleming Pharmaceuticals Pvt Ltd
About Largus Fleming Pharmaceuticals Pvt Ltd
Data last updated:
Largus Fleming Pharmaceuticals Pvt Ltd is a private limited company based in Kolkata, West Bengal, India. It operates in the real estate leasing and property management segment of the real estate sector. It was incorporated on 09 February 1976 and has been in existence for over 50 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24231WB1976PTC030424.
The company has an authorised share capital of ₹6 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors Rahul Nangalia and Sushila Nangalia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2 Auckland Place 6th Floor, Kolkata, West Bengal, India – 700017.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.75 Lakh, a growth of 13% compared to the previous year. For the same year it recorded a net loss of ₹28,040 (net margin -1.2%) and EBITDA of ₹23.47 Lakh (EBITDA margin 98.8%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 12% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Largus Fleming Pharmaceuticals Pvt Ltd's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address2 Auckland Place 6th Floor, Kolkata, West Bengal, India – 700017
- IndustryReal Estate, Real Estate Leasing
To see the full contact details of Largus Fleming Pharmaceuticals Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Largus Fleming Pharmaceuticals Pvt Ltd
FY 2025 filings availableLargus Fleming Pharmaceuticals Pvt Ltd reported revenue of ₹23.75 Lakh (up 13% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 13% growth in the latest year. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹23.47 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹28,040 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 98.8% | ||||
| Net Profit Margin | -1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Largus Fleming Pharmaceuticals Pvt Ltd, buy the company report.
Board of directors of Largus Fleming Pharmaceuticals Pvt Ltd
Largus Fleming Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Nangalia Also directs: Altius Builders Private Limited, Shakespear Promoters Pvt Ltd, Aisha Developers LLP and 5 more | Director | 14 Mar 2011 | 15 Years 7 Months | Current |
| Sushila Nangalia Also directs: Russel Developers Pvt Ltd, Altius Builders Private Limited, Manushri Projects Private Limited and 5 more | Director | 14 Mar 2011 | 15 Years 7 Months | Current |
Auditor
Largus Fleming Pharmaceuticals Pvt Ltd is audited by N. BEHERA & COMPANY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N. BEHERA & COMPANY | FY 2017 | 327287E |
Shareholding
The shareholding of Largus Fleming Pharmaceuticals Pvt Ltd is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Largus Fleming Pharmaceuticals Pvt Ltd, buy the company report.
Legal cases
No court or tribunal cases involving Largus Fleming Pharmaceuticals Pvt Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Largus Fleming Pharmaceuticals Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Largus Fleming Pharmaceuticals Pvt Ltd; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Largus Fleming Pharmaceuticals Pvt Ltd has 5 board changes on record since 2011: 2 appointments and 3 cessations. The latest: Amar Nath Shroff ceased to be Director on 26 Sep 2012.
Frequently asked questions
Largus Fleming Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in real estate leasing, within the real estate industry. It was incorporated on 09 February 1976 (50+ years old) and is registered under CIN U24231WB1976PTC030424.
Largus Fleming Pharmaceuticals has 2 current directors:
- Rahul Nangalia - Director
- Sushila Nangalia - Director
The latest financial statements of Largus Fleming Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Largus Fleming Pharmaceuticals is U24231WB1976PTC030424. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Largus Fleming Pharmaceuticals was incorporated on 09 February 1976, making it 50+ years old. It is registered with the Registrar of Companies, Kolkata.
Amar Nath Shroff ceased to be Director on 26 Sep 2012. Pradeep Kumar Saraf ceased to be Director on 26 Sep 2012. Surendra Kumar Saraf ceased to be Director on 26 Sep 2012. Largus Fleming Pharmaceuticals has 5 board changes on record in total.
The registered office of Largus Fleming Pharmaceuticals is at 2 Auckland Place 6th Floor, Kolkata, West Bengal, India – 700017.
Largus Fleming Pharmaceuticals operates in the real estate industry, in the real estate leasing segment.
The compliance status of Largus Fleming Pharmaceuticals is compliant as of 25 September 2026. The company is actively filing with the Registrar of Companies.
Largus Fleming Pharmaceuticals can be reached at its registered office: 2 Auckland Place 6th Floor, Kolkata, West Bengal, India – 700017.